Rammeaftale for levering af ulicenserede specialprodukter

This tender for unlicensed pharmaceutical products is generally well-structured, with clear objectives and reasonable eligibility criteria. However, it lacks explicit evaluation criteria and details on sustainability initiatives, which could be improved.

The tender appears to be compliant with standard open procedure rules, including the use of a relevant CPV code and disclosure of estimated value. The mention of a minimum tender period of 25 days suggests adherence to some regulatory timeframes, although the overall deadline length is not explicitly assessed as reasonable or unreasonable without further context. The absence of reported disputes or suspensions is a positive indicator.

The description of the framework agreement is clear, outlining the need for unlicensed specials to meet patient clinical needs. The requirements for suppliers, such as flexibility and quality assurance, are well-articulated. The AI-extracted requirements also provide a good overview of expectations.

Most basic information is present, including title, reference, organization, estimated value, contract duration, and start date. However, the 'Documents with content/summaries: 0' flag indicates that the actual tender documents, which would contain critical details like evaluation criteria and detailed specifications, are not accessible for analysis, impacting the perceived completeness.

The tender specifies an open procedure, discloses the estimated value, and mentions electronic submission, promoting fairness. The requirement for suppliers to be 'Specials' Licence holders is a necessary qualification, not an unfair tailoring. The inclusion of pre-market engagement meetings is a positive step towards transparency. The absence of specific tailored requirements for individual companies is noted.

The tender mentions 'electronic submission' which is positive for practicality. However, the 'Checks' section flags 'No e-submission,' which creates a contradiction. The lack of explicit financing information and potential issues with the contract start date relative to the submission deadline (though not explicitly flagged as an issue here) could be improved.

Key fields such as title, reference, organization, value, and deadlines are populated. The status is 'active', and there are no reported disputes or suspensions. Dates appear logically sequenced, with the contract start date following the submission deadline. The CPV code and NUTS code are also provided.

The tender lacks explicit mentions of green procurement, social aspects, or innovation. It is also not indicated as EU funded. This suggests a moderate to low focus on sustainability criteria within this procurement process.